Home LiteratureArticle Details
PMID: 12010024 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Computational drug design accommodating receptor flexibility: the relaxed complex scheme.

Journal of the American Chemical Society ·Vol. 124 ·No. 20 ·2002-05-22 ·Pages 5632-3

Lin JH, Perryman AL, Schames JR, McCammon JA

Abstract

A novel computational methodology for drug design that accommodates receptor flexibility is described. This "relaxed-complex" method recognizes that ligand may bind to conformations that occur only rarely in the dynamics of the receptor. We have shown that the ligand-enzyme binding modes are very sensitive to the enzyme conformations, and our approach is capable of finding the best ligand-enzyme complexes. This new method serves as the computational analog of the experimental "SAR by NMR" and "tether" methods, which permit a building block approach for constructing a very potent drug.

MeSH Terms
Algorithms Computer Simulation Drug Design Ligands Models, Molecular Protein Conformation Receptors, Drug/chemistry Tacrolimus Binding Proteins/chemistry Thermodynamics
Chemicals
Ligands Receptors, Drug Tacrolimus Binding Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lin Jung-Hsin
Howard Hughes Medical Institute, Department of Chemistry & Biochemistry, and Department of Pharmacology, University of California at San Diego, 92093-0365, USA. jlin@maccammon.ucsd.edu
Perryman Alexander L
Schames Julie R
McCammon J Andrew
Article Info
Journal
Journal of the American Chemical Society
Abbr.
J Am Chem Soc
ISSN
0002-7863
Published
2002-05-22
Pages
5632-3
Language
English
Region
United States
NLM ID
7503056
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com